Some anti-phosphocholine antibodies protect mice against challenge with certain, but not all, pneumococcal types. We found that both their isotype and reactivity with the cell wall C-polysaccharide of encapsulated pneumococci, as measured by immunodiffusion, were important in predicting the protective activity of anti-phosphocholine antibodies. We propose that the specificity of the protective antibodies includes the backbone of the phosphocholine-containing structure.
There is substantial evidence for the virulence-promoting activity of pneumococcal capsular polysaccharides. Protection against pneumococcal diseases, mediated by anticapsular antibodies, is type specific (19, 24) . Tillett showed that immunizing rabbits with a rough pneumococcal strain or heat-killed encapsulated strains yielded heterologous protection (31, 32) . Others (3, 10, 11, 13) showed that noncapsular structures could induce immunity against several pneumococcal types. Au and Eisenstein demonstrated non-type-specific protection induced with subcellular fractions prepared from unencapsulated pneumococci which was not type specific (1) . These workers showed that antibodies to the Forssman antigen, present in pneumococci, were not protective in their assay system (2) . They suggested that the protective noncapsular antigen(s) might be in the rough cell wall.
Recently, Briles et al. (7, 8) showed that monoclonal antibodies with phosphocholine (PC)-binding activity provided protection against intravenous challenge with a type 3 pneumococci strain in both healthy and immunodeficient CBA/N mice. Immunoglobulin M and IgG, but not IgA anti-PC monoclonal antibodies exerted this protective activity (7). Creactive protein, a non-immunoglobulin PCbinding protein (26) , also showed protection against pneumococcal infection in mice (25) .
In the experiments to be reported, strains representing types 1, 2, 3, 4, 5, 6A, and 7F were obtained from the collection of the Bureau Facklam, Centers for Disease Control). Strain SRC-2, a noncapsular variant of type 2 yielding a quellung reaction with anti-cell wall polysaccharide antisera, was obtained from Gerald Schiffman, State University of New York, Brooklyn (29) . Mucoid colonies, taken from 5% sheep blood agar, were inoculated into brain heart infusion medium (Difco Laboratories, Detroit, Mich.) supplemented with 0.2% sucrose and 1% 2.0 M Na2HPO4. The culture was incubated at 37°C in 5% CO2 without agitation, and the concentration of organisms was determined by absorbance at 545 nm. Organisms for challenge and serological reactions were taken at the midlog phase of growth.
The antisera and monoclonal antibodies are listed in Table 1 Two other general groups of PC-binding antibodies were also investigated in the protection assay. The first, T15, an IgA immunoglobulin, was induced by injecting BALB/c mice i.p. with pristane (27) . T15 precipitated strongly with all of the pneumococcal suspensions and the purified C-ps. Despite this and its reported binding with PC, T15 did not confer passive protection. This is best explained by the inability of IgA to activate complement after its interaction with antigen. This secondary biological activity is essential for inducing an opsonic effect (21) . The observation that IgA anti-PC does not confer protection against pneumococcal infection despite its interaction with the organism was reported by Briles et al. (7) . The second PCbinding antibody assayed for protection was rabbit type 27 antiserum. The type 27 capsular polysaccharide contains PC (Fig. 3b) , but the sugar backbone differs from that of the C-ps (4, 5, 23) . Type 27 antiserum has been reported to bind PC (5), but it does not precipitate with pneumococcal suspensions or the C-ps. The failure of the type 27 antiserum, despite its PCbinding activity (5) , to confer heterologous protection may be related to its inability to precipitate with the pneumococcal suspensions and the purified C-ps. Our results indicate a correlation between the precipitin reaction with PC-containing structures and the protective activity of these reagents. We suggest that the protective activity of PC-binding antibodies is related both to their additional specificity for the sugar backbone of the C-ps and to their secondary biologi- 
(b) FIG. 3 . Structure of two PC-containing pneumococcal polysaccharides: (a) C-ps, cell wall polysaccharide (27) , and (b) type 27 capsular polysaccharide (4) .
cal activities such as complement activation (34) . It is likely that the protective activity of these PC-binding antibodies is modified by the amount of capsular polysaccharide and the availability of the PC-containing structure to interact with the antibody.
Antibodies reactive with PC can be induced by a wide variety of organisms (33) , including strains of Proteus morganii, Lactobacillus acidophilus, Trichoderma sp. and Fusarium sp., of murine origin, and Ascaris suum, Nippostrongylus brasiliensis, and Hemochus sp., in addition to the pneumococcal C-ps and type 27 polysaccharide (15, 27) . The exact structures of most of the PC-containing antigens of the above organisms have not been determined.
A partial amino acid sequence of the heavy and light polypeptide chains of HYPC1613 has been found to be similar to that of other PCbinding monoclonal antibodies (Clarke et al., in press). The VL region has been sequenced through the first 50 amino acids and has been found to be identical to the VL region of the PCbinding myeloma M603. The VH region sequence is longer by two amino acids than other PC-binding myeloma proteins. X-ray crystallographic 3D structure (35) and sequence-conformation analyses of M603 (36) and T15 have revealed correlations between the light chain sequence and combining site conformations. The M603 combining site for PC has ample room for a polysaccharide backbone, such as C-ps, to approach the combining region; this phenomenon may be extrapolated to the HYPC1613. Thus, in addition to their common PC-binding property, antibodies induced by diverse sources may have structural differences (14) .
It is likely that the pneumococcal structure that reacts with the HYPC1613 and the SRC-2 rabbit antiserum to result in a protective activity is the C-ps. The structure of the C-ps repeat unit has been proposed by Jennings et al. (20) . It is composed of a pentasaccharide repeating unit with a ribitol phosphate linkage (Fig. 3a) . PC is situated at 0(6) of the nonacetylated galactosamine residue. These workers found identical Cps in the cell walls of strains representing three capsular types. In earlier studies, Brundish and Baddiley (9) and Paxton et al. (28) reported identity among C-ps isolated from numerous capsular types. Although PC is a component of mammalian membranes and some serum proteins, "natural" anti-PC antibodies and other PC-binding proteins such as C-reactive protein do not seem to be disease-causing molecules (22 
